Sirtuin 1 alleviates alcoholic liver disease by inhibiting HMGB1 acetylation and translocation
PeerJ · 27.11.2023 · 11 · e16480
DOI: 10.7717/peerj.16480 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, online erschienen am 27.11.2023. Verfasst von Juan Fu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Hainan General Hospital/Hainan Affiliated Hospital of Hainan Medical University, Haikou, China. Hauptthemen laut MEDLINE: HMGB1 Protein, Liver Diseases, Alcoholic, Sirtuin 1. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hainan Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Alcoholic liver disease (ALD) encompasses a spectrum of liver disorders resulting from prolonged alcohol consumption and is influenced by factors such as oxidative stress, inflammation, and apoptosis. High Mobility Group Box 1 (HMGB1) plays a pivotal role in ALD due to its involvement in inflammation and immune responses. Another key factor, Sirtuin 1 (SIRT1), an NAD + -dependent deacetylase, is known for its roles in cellular stress responses and metabolic regulation. Despite individual studies on HMGB1 and SIRT1 in ALD, their specific molecular interactions and combined effects on disease advancement remain incompletely understood.
Methods
Alcohol-induced liver injury (ALI) models were established using HepG2 cells and male C57BL/6 mice. HMGB1 and SIRT1 expressions were assessed at the mRNA and protein levels usingreverse transcription-quantitative polymerase chain reaction, western blot, and immunofluorescence staining. The physical interaction between HMGB1 and SIRT1 was investigated using co-immunoprecipitation and immunofluorescence co-expression analyses. Cellular viability was evaluated using the CCK-8 assay.
Results
In patients with clinical ALI, HMGB1 mRNA levels were elevated, while SIRT1 expression was reduced, indicating a negative correlation between the two. ALI models were successfully established in cells and mice, as evidenced by increased markers of cellular and liver damage. HMGB1 acetylation and translocation were observed in both ALI cells and mouse models. Treatment with the SIRT1 agonist, SRT1720, reversed the upregulation of HMGB1 acetylation, nuclear translocation, and release in the ethyl alcohol (EtOH) group. Furthermore, SIRT1 significantly attenuated ALI. Importantly, in vivo binding was confirmed between SIRT1 and HMGB1.
Conclusions
SIRT1 alleviates HMGB1 acetylation and translocation, thereby ameliorating ALI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Hainan General Hospital/Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.
- Department of Oral and Maxillofacial Surgery, Hainan General Hospital/Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.
Förderung
- Hainan Provincial Natural Science Foundation of China
Zitieren
APA
Fu, J., Deng, W., Ge, J., Fu, S., Li, P., Wu, H., Wang, J., Gao, Y., Gao, H., & Wu, T. (2023). Sirtuin 1 alleviates alcoholic liver disease by inhibiting HMGB1 acetylation and translocation. PeerJ, 11, e16480. https://doi.org/10.7717/peerj.16480
Vancouver
Fu J, Deng W, Ge J, Fu S, Li P, Wu H, et al. Sirtuin 1 alleviates alcoholic liver disease by inhibiting HMGB1 acetylation and translocation. PeerJ. 2023;11:e16480. doi:10.7717/peerj.16480
BibTeX
@article{Fu2023,
author = {Fu, Juan and Deng, Wei and Ge, Jun and Fu, Shengqi and Li, Panpan and Wu, Huazhi and Wang, Jiao and Gao, Yi and Gao, Hui and Wu, Tao},
title = {Sirtuin 1 alleviates alcoholic liver disease by inhibiting HMGB1 acetylation and translocation},
journal = {PeerJ},
year = {2023},
volume = {11},
pages = {e16480},
doi = {10.7717/peerj.16480}
}
EUVIMED